The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study

BACKGROUND: Dopamine D2-like receptors are attenuated in aldosterone producing adenoma, lead to overproduction of aldosterone in affected patients, and thus reported to serve as a potential treatment target for primary aldosteronism. The D2 dopamine receptor agonist bromocriptine has been used clini...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Wu, Vin-Cent, Wu, Che-Hsiung, Yang, Ya-Wen, Huang, Kuo-How, Chang, Chia-Hui, Yang, Shao-Yu, Lin, Yen-Hung, Wu, Kwan-Dun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652803/
https://ncbi.nlm.nih.gov/pubmed/29100412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20670
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak